This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Sep;42(8):839-40; author reply 840.

doi: 10.1046/j.1526-4610.2002.02192.x.

Rizatriptan 5mg is not efficacious for migraine in adolescents

PMID: 12390657
DOI: 10.1046/j.1526-4610.2002.02192.x

Comment

Rizatriptan 5mg is not efficacious for migraine in adolescents

Morris Maizels. Headache. 2002 Sep.

. 2002 Sep;42(8):839-40; author reply 840.

doi: 10.1046/j.1526-4610.2002.02192.x.

Author

PMID: 12390657
DOI: 10.1046/j.1526-4610.2002.02192.x

No abstract available

PubMed Disclaimer

Comment on

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
Teall J, Tuchman M, Cutler N, Gross M, Willoughby E, Smith B, Jiang K, Reines S, Block G. Teall J, et al. Headache. 1998 Apr;38(4):281-7. doi: 10.1046/j.1526-4610.1998.3804281.x. Headache. 1998. PMID: 9595867 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information